BOSTON - NMT Medical, Inc. has received Pre-Market Approval from the US
Food and Drug Administration for the sale of its STARFlex cardiac septal repair
implant in the United States
for patients with ventricular septal defects (VSD), an opening between the
right and left ventricle in the lower chambers of the heart.